Ticker Details
Vivos Therapeutics, Inc.
IPO Date:	July 7, 2020
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$13.71M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 4.98%
Avg Daily Range (30 D):	$0.05 | 3.98%
Avg Daily Range (90 D):	$0.06 | 3.80%

Institutional Daily Volume
Avg Daily Volume:	.8M
Avg Daily Volume (30 D):	.17M
Avg Daily Volume (90 D):	.13M

Trade Size
Avg Trade Size (Sh.):	233
Avg Trade Size (Sh.) (30 D):	129
Avg Trade Size (Sh.) (90 D):	143

Institutional Trades
Total Institutional Trades:	25
Avg Institutional Trade:	$.96M
Avg Institutional Trade (30 D):	$.65M
Avg Institutional Trade (90 D):	$.65M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$1.05M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$.84M
Avg Closing Volume:	12.46K

News

Jan 21, 2026 @ 6:00 PM Global Sleep Apnea Devices Market is Expected to C... Source: Delveinsight

Jan 20, 2026 @ 10:31 PM Vivos Therapeutics Announces Closing of Exercise o... Source: Na

Dec 15, 2025 @ 10:30 PM Vivos Therapeutics to Participate in Online Firesi... Source: Vivos Therapeutics, Inc.

Aug 20, 2025 @ 8:24 PM Vivos Reports 7% Sales Drop Source: Jesterai

Jun 27, 2024 @ 11:30 AM Vivos Therapeutics Announces Positive Results From... Source: Vivos Therapeutics, Inc

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.77	$-.49	$-.55
Diluted EPS	$-1.77	$-.49	$-.55
Revenue	$17.32M	$6.78M	$3.82M
Gross Profit	$9.65M	$3.94M	$2.11M
Net Income / Loss	$-17.1M	$-5.4M	$-5.01M
Operating Income / Loss	$-16.32M	$-4.73M	$-4.87M
Cost of Revenue	$7.67M	$2.85M	$1.71M
Net Cash Flow	$-3.22M	$-1.32M	$-1.86M
PE Ratio

Splits
Oct 27, 2023	1:25